Profil
Hiroshi Miyamoto currently works at ImmunoFrontier, Inc., as President & Representative Director from 2018.
Aktive Positionen von Hiroshi Miyamoto
| Unternehmen | Position | Beginn |
|---|---|---|
ImmunoFrontier, Inc.
 ImmunoFrontier, Inc. Miscellaneous Commercial ServicesCommercial Services ImmunoFrontier, Inc. is a holding company that specializes in the research and development of cancer vaccines. It develops CHP cancer protein vaccines and multifunctional cancer DNA vaccines. The firm also establishes technology solutions for promoting the creation of cancer DNA vaccines and therapeutics for immune diseases. The company was founded by Shiku Hiroshi on October 5, 2004 and is headquartered in Tokyo, Japan. | Präsident | 01.10.2018 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
ImmunoFrontier, Inc.
ImmunoFrontier, Inc. Miscellaneous Commercial ServicesCommercial Services ImmunoFrontier, Inc. is a holding company that specializes in the research and development of cancer vaccines. It develops CHP cancer protein vaccines and multifunctional cancer DNA vaccines. The firm also establishes technology solutions for promoting the creation of cancer DNA vaccines and therapeutics for immune diseases. The company was founded by Shiku Hiroshi on October 5, 2004 and is headquartered in Tokyo, Japan. | Commercial Services |
